An interventional study to evaluate the effect of shankupushppi choornam in premenstrual syndrome in participants with age group of 20-40 years.
- Conditions
- Unspecified behavioral syndromes associated with physiological disturbances and physical factors. Ayurveda Condition: PMS,
- Registration Number
- CTRI/2025/05/086928
- Lead Sponsor
- Dr Aiswarya Preman UV
- Brief Summary
Premenstrual syndrome refers to regular monthly experience of physiological and emotional distress in women of reproductive age, usually during several days preceding menses. This syndrome is typically characterized by nervousness, depression, fluid retention. The premenstrual syndromes become typically obvious during the luteal phase of the menstrual cycle.In ayurveda this stage is correlates to Rituvyateetakala during which Pithakopa and vata sanchayam occurs. Shankhapushpi churna is Seeta veerya and Madhura vipaka hence it is vata pitta samana in nature. The objective of the study is to find the effect of Shankhapushpi churna in Premenstrual Syndrome. The study design will be interventional study pre and post test with a sample size of 23. Females of age group 20-40 years attending the out-patient department of prasutitantra and Streeroga, fulfilling the American College of Obstetrics and Gynecology criteria (ACOG) of Premenstrual syndrome will be selected for the study. Study tool includes ACOG criteria, Case proforma, and symptom assessment by Premenstrual syndrome premenstrual syndrome score scale. Shankhapushpi churna will be given in a dose of 6gm with 30 ml of milk twice daily after food. Administration of drug will be starting starting from 10th day of menstruation for 14 days in 2 consecutive menstrual cycles. Participants will be assessed on 0th day, 31 day and on 61st day during the study period. Result will be analyzed statistically and summarized to arrive at conclusions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 23
- Participants whose menstrual cycle is regular with a duration of 2-6 days and 28 days of interval.
- Participants who are competent and willing to give written consent.
- Participants of age group 20-40 years diagnosed as Premenstrual syndrome using ACOG criteria with score 40 or above assessed by Premenstrual syndrome scale.
- Participants undergoing prolonged medication for uncontrolled and chronic systemic illness.
- Participants with mood disturbances or any other psychiatric disorder.
- Participants with menopausal syndrome.
- Participants who are taking oral contraceptives and hormonal preparations.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the score of Premenstrual symptoms assessed by premenstrual syndrome scale 0th day ,31st and 61st day
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Govt Ayurveda college Hospital for Women and Children Poojappura Thiruvananthapuram
🇮🇳Thiruvananthapuram, KERALA, India
Govt Ayurveda college Hospital for Women and Children Poojappura Thiruvananthapuram🇮🇳Thiruvananthapuram, KERALA, IndiaDr Aiswarya Preman UVPrincipal investigator9496785280aiswaryamalu13@gmail.com